跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
QINLOCK 50 MG COMPRIMIDOS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
QINLOCK 50 MG COMPRIMIDOS
Approved
STANDARD
QINLOCK 50 MG COMPRIMIDOS
Deciphera Pharmaceuticals (Netherlands) B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 27, 2023
Approval ID
dd11b1fac94642a7
Company
Deciphera Pharmaceuticals (Netherlands) B.V.
Type
Standard
Approval Details
Approval Id
dd11b1fac94642a7
Drug Cima Aemps Name
QINLOCK 50 MG COMPRIMIDOS
Register Number
1211569001
Holder Company Name
Deciphera Pharmaceuticals (Netherlands) B.V.
Marketing Company Name
Deciphera Pharmaceuticals (Netherlands) B.V.
Holder Company Detail Path
/organization/deciphera-pharmaceuticals-netherlands-bv
Marketing Company Detail Path
/organization/deciphera-pharmaceuticals-netherlands-bv
Authorization Date
2023-04-27
Dosage Form
COMPRIMIDO
Dose
50 MG
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Deciphera Pharmaceuticals (Netherlands) B.V.
Company Detail Path
/organization/deciphera-pharmaceuticals-netherlands-bv
Company Information
Pharmaceutical Company Name
Deciphera Pharmaceuticals (Netherlands) Bv
Country Name
Belgium
City Name
unknown,unknown,country_be
Address
Unknown Belgian address
Active Ingredients
RIPRETINIB
50 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 27, 2023
Approval ID
dd11b1fac94642a7
Type
Standard
Back to CIMA-AEMPS Approvals